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11.-8, PGE 2 and MMP-3 productions but did not modify the AGG 
inhibition. Nevertheless, ASU promoted the restoration of AGG 
synthesis after a 3-days pre-treatment with IL-113, 
Conclusion: From this work, we can conclude that ASU shows 
anti-inflammatory properties by inhibiting PGE 2, IL-6 and IL-8. 
Furthermore, it stimulates AGG production and accumulation i
the extracellular matrix and promotes matrix formation after IL-113 
treatment. In parallel, it decreases MMP-3 production in both 
untreated and IL-ll3-treated cultures. Taken together, these 
results suggest that ASU could have a structural effect in OA by 
decreasing matrix degradation and restoring its formation. 
This work was supported by an unrestricted educational grant 
from Pharmasciences laboratories. 
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LONG-TERM EFFECT OF MULTIPLE COURSES OF INTRA- 
ARTICULAR INJECTIONS OF SODIUM HYALURONAN 
DURING THE DEVELOPMENT OF OSTEOARTHRtTIS 
T Toyoguchi, M Daley, D Amiel 
University of California at San Diego, Department of 
Orthopaedics, Connective 77ssue Biochem, La Jolla CA; 
Sanofi Pharmaceuticals, Inc* NY NY USA 
Aim: Effects of hyaluronan (HA) therapy on disease progression is 
of clinical interest. While the half-life of HA is short (hours), the 
duration of pain relief can be more than 1 year. Several in vivo ani- 
mal studies have reported on early term effectiveness of HA treat- 
ment on experimentally induced osteoarthritis (OA). Because of 
the reported half-life, a question arose regarding the effectiveness 
of this treatment during the development of OA over the long 
term. Our purpose is to carry out a controlled long-term study 
and compare a sequential series of intra-articular injections of HA 
(Hyalgan®: MW 5-7.3 X 105 daltons) to a single series during the 
development of OA. 
Methods: Fifty mature New Zealand white rabbits with closed 
epiphysis (five groups of 10 animals each) had their femoral 
condyle and tibial plateau assessed at 26 weeks post surgical 
development of OA. Group 1 had only their ACL transected 
(ACL'r). Group 2 had a single series of 5 intra-articular HA injec- 
tions 4 weeks post ACLT. Group 3 had a single series of HA vehi- 
cle (saline phosphate buffer (PBS)) injections 4 weeks post ACLT. 
Group 4 had a sequential series of 5 injections of HA at 4 and 13 
weeks post ACLT. Group 5 had a sequential series of 5 injections 
of HA vehicle (PBS) at 4 and 13 weeks post ACLT. All animals 
were sacrificed at 26 weeks and graded as follows: Grade 1 intact 
surface; Grade 2 minima/fibrillation; Grade 3 overt fibrillation; 
Grade 4a 0ram <erosion < 2mm; Grade 4b 2ram <erosion <5ram; 
and Grade 4c 5mm <erosion. 
Results: All groups had severe articular degradation of the 
femoral condyle cartilage. There was a slight benefit of intra-artic- 
ular injections of PBS (Group 3) compared with the ACLT Group 
1. The 5XHA/4weeks (Group 2) and sequential injections 
10XHA/4weeks (Group 4) seemed to elicit a slight benefit on pre- 
venting degradation of cartilage. On the tibial plateau, repeat 
courses of HA (Group 4) reduced the degree of articular cartilage 
degradation when compared with all treatment groups. 
Conclusions: Multiple courses of HA treatment may be able to 
modify the disease progression of OA of the knee, and may be 
useful in long-term management. 
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RISK FACTORS IN A CONTINUOUS SERIES OF 66 HIP 
OSTEOARTHRITIC (HOA) PATIENTS: 
A PROSPECTIVE STUDY 
M G Lequesne, N Dang, Leopold Bellan 
75014 Paris, France 
Aim: To confirm the risk factors (RF) of HOA and their possible 
associations. Is there still room for primary (prim) HOA? 
Method: All new out-patients (lots) with HOA (ACR criteria) were 
screened for the following RF: 1. Congenital dysplasia (measured 
with femorocoxometer). 2. Acetabular protrusio. 3. Tilt defor- 
mity. 4. Coxa plana. 5. Familial clustering (Faro clust) for HOA 
(first degree relatives). 6. Sport: at least 10 years of practice with 
competition in soccer, rugby, tennis, basket ball, handball, judo, 
karate, long distance running. 7. Hip hypersollicitation at work 
(hard work): more than 15 years with heavy loads. 8. Trauma. 9. 
Femoral head necrosis. For each: sex, age at onset of pain, side 
(s) involved and weight 
Results: Out of 66 pts, 30 had bilateral HOA, 42 were females 
(63%), 6 were overweight. Age at onset: 54+16.1 years. Main RF: 
I-SPORT: 20 pts (30%), of whom 12(18%) (age:47± 12.8 years) 
had no other RF and 8 had associated RF i.e. Fam-Clust 5 pts, 
dysplasia 2, trauma 1. II-DYSPLASIA: 14 (2 1%) ; with no other 
RF: 11 (age 46±12.6). Ill- FAM CLUST (dysplasia excluded as 
hereditary by itself): 11 (t6.6%), of whom 5(7.6%) had no other 
RE IV-Rarer conditions: protrusio 3, hard work 2, trauma 2, necro- 
sis 2. V Tilt deformity (5pts) was present only in sportsmen. 
Conclusion: Two 'new' RF prevail : sport (the only RF in 18%) 
and fam-clust (the only RF in 7.5%). Dysplasia is still present (the 
only RF in 16.6%)Out of 66 pts, 9 have association of 2 RE There 
remain 14 pts (2 1%) without any RE It may be said also that prim 
HOA accounts for 19 pts (29%), of whom 5 with Fam Clust (age: 
64+1). 
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WHAT CONSTITUTES CHANGE IN RESPONSE TO 
INTERVENTIONS FOR OSTEOARTHRITIS? 
R Campbell, B Quilty, P Dieppe 
MRC HSRC, Bristol, UK 
Aim: To compare changes in pain and disability recorded by the 
WOMAC with those reported by patients during in-depth inter- 
views. 
Methods: As part of a trial of the effects of a package of phys- 
iotherapy for the treatment of patello-femoral osteoarthritis (OA) 
a nested qualitative study of 20 of the participants was under- 
taken. WOMAC was used as the primary outcome measure in 
the trial and was recorded immediately before and 5 months 
after the intervention. Semi-structured in-depth interviews with 
the 20 patients were carried out approximately 3 months after 
the intervention. They were tape-recorded, transcribed and 
analysed by two independent observers, who were blind to the 
quantitative data. The qualitative and quantitative data were 
then compared. 
Results: WOMAC data indicated that pain was better in 14 
patients, worse in 3 and unchanged in 3. For disability, improve- 
ment was seen in 7, no change in 6 and worsening in 7. In con- 
trast, data from the qualitative interviews indicated that only one 
patient thought e was worse (either for pain or disability), 6 
thought here were about the same or were unsure and the 
remaining 13 considered themselves better. There were some 
marked discrepancies between the two sorts of data, some 
patients who showed worsening on WOMAC scores considering 
themselves to be much better and vice-versa. 
Conclusions" Quantitative and qualitative methods of assessing 
change in response to an intervention for knee OA have shown 
worrying differences. It is unlikely that these can be explained by 
the rather different timing of the two assessments. The context 
and way in which responses are elicited may make a big differ- 
ence to reported outcomes in OA. 
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ASSESSING CHANGE IN PAIN AND DISABILITY STATUS 
FOR KNEE AND HIP OSTEOARTHRITIS USING THE 
NEW ZEALAND SCORE 
C Sanders, TJ Peters, P Dieppe, J Donovan 
MRC HSRC, Bristol, UK 
Aim: To assess change in pain and disability status, and factors 
influencing such changes, amongst a population based sample 
with osteoarthritis of the hip and/or knee. 
Methods: Individuals in the Somerset and Avon Survey of Health 
(SASH) who reported knee/hip pain were assigned New Zealand 
(NZ) scores between 1992 and 1994. Respondents were followed 
up (25% random sample, n=587) between 1998 and 1999, when 
the NZ score was repeated (minus the clinical component). 
Separate analyses were conducted for knees and hips, with the 
worse joint at follow-up used as the index joint for analysis of 
change. Adjusting for baseline score, age, sex and surgery, vari- 
ous potential predictors were considered for the follow-up score 
using univariate and multivariable r gression. 
Results: Response rate was 66% (n=390). For knees, the mean 
score at baseline of 21.4 (95% CI 19.6, 23.2, n=283) had wors- 
ened at follow-up, to 28.5 (CI 26.3, 30.6). Corresponding figures 
for hips were 21.8 (C119.2, 24.5: n=204), and 27.2 (CI 24.8, 29.7). 
For knees, women had deteriorated to a greater degree than men 
(p=0.05). Older age groups had worse scores at baseline and fol- 
low-up, and deteriorated to a greater degree than younger age 
groups (p=0.004). The age differences were greater for women 
than for men (p=0.009). Multivadable analysis found that the fol- 
lowing variables were independently associated with change in 
NZ score for knees: employment status (p=0.006), social class 
(p=0.009), hypertension (p=0.03), and having consulted a com- 
munity doctor between baseline and follow-up (p<0.0001). For 
hips, there were several univariate associations, but these did not 
remain in multivariable analysis. 
Conclusions: The NZ score appears to be sensitive to change in 
pain and disability status. Age and gender differences support 
findings of previous research. The association between change in 
knee score and hyper-tension may be confounded by BMI (cur- 
rently being explored). Associations with employment status and 
social class indicate that both these aspects have consequences 
for the prograssion of OA symptoms. 
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VISCOSUPPLEMENTATION WiTH HYLAN GF-20 IN KNEE 
OSTEOARTHRITIS: ASSESSMENT OF THE PREDICTIVE 
FACTORS OF LONG-TERM EFFICACY 
P Mathieu, T Conrozier, AM Schott, 1 Laurent, JF Marc 1, 
E Vignon z 
~Savoye, 2RhSne-Alpes Group for the Viscosupplementation 
Evaluation and Claude Bernard University, Lyon. France 
Rationale: Viscosupplementation with Hylan GF-20 is widely 
used in the treatment of knee osteoarthritis (OA) but predictive 
factors of its efficacy have not been yet fully demonstrated. 
Aim: To determine the predictive factors of long term efficacy of
viscosupplementation by Hylan GF-20 in patients with knee 0A. 
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Patients and methods: 155 patients (80 women, 75 men, mean 
age 69, mean disease duration 6 years, mean BMI 27.9) were 
questioned, using a standardized questionnaire, about the effica- 
cy and the satisfaction towards the treatment, 7 and 14 months 
after 3 injections of Hylan GF-20 for knee OA (ACR criteria). 
Radiological grade of OA (Kellgren and Lawrence-KL), topogra- 
phy of joint space narrowing (tibiofemoral, patello femoral or 
global), way of injection (anterior, superolateral or superomedial 
routes), synovial fluid (SF) volume (absent, mild, or important if 
effusion during treatment), and adverse events were collected. 
Logistic regressions, taking into account age, sex, BMI, and time 
between treatment and interview, were performed to determine 
the predictive factors of efficacy of the treatment. 
Results: Safety was considered as excellent or good in 96.2% of 
the cases. At month 7 and 14 the percentage of patients atisfied 
with the treatment was respectively 77.9% and 48.5%. Factors 
associated with good efficacy of the treatment (p<0.05) were: 
presence of a mild SF effusion (OR 6.9), tibiofemoral joint space 
narrowing (OR 2.68), radiological calcinosis of the meniscus (OR 
1 3.3) lateral and medial mutes of injection (OR 2.59), and KL 
grade IV (OR 9.2). 
Conclusion: The study demonstrates that several factors are 
strongly associated with good response to visco supplementa- 
tion therapy in patients suffering from knee OA. These data could 
be helpful to select patients who may derive benefit from visco- 
supplementation therapy. 
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COMPARISON OF AN ORAL ENZYME COMBINATION WITH 
DICLOFENAC IN PATIENTS WITH PAINFUL OSTEOARTHRI- 
TIS OF THE KNEE BY META-ANALYSIS 
M.W. Loes 1, V.W. Rahlfs 2, A Rozenahl 2
IArizona Pain Institute, Phoenix, AZ; 2idv, Gauting, Germany 
Objective: It was intended to compare the fficacy and safety of 
an oral enzyme-rutosid combination (ERC), containing rutosid 
and the enzymes bromelain and trypsin, with that of dictofenac in 
patients with osteoarthritis of the knee, based on the meta-analy- 
sis of three studies. 
Methods: For the meta-analysis three double-blind randomized 
controlled clinical trials comparing the fficacy and safety of ERC 
with that of diclofenac in patients with osteoarthritis of the knee 
were available. The trials had been performed according to iden- 
tical study protocols, but due to small sample sizes sufficient evi- 
dence of the study objectives could not be achieved. Pooling of 
the studies lead to an adequate sample size of 195 patients. Re- 
analyses of the individual studies were restricted to the primary 
study criteria Lequesne's algofunctional index and the sum score 
of a complaint index, in order to demonstrate quivalent efficacy 
of ERC and diclofenac. First line analysis was performed with the 
Wilcoxon-Mann-Whitney procedure, testing the two primary cri- 
teria in sequential order. In addition a summarizing analysis of all 
efficacy criteria was performed, using the directional non-para- 
metric test of the efficient Wei-Lachin procedure. For the purpose 
of meta-analysis, results were combihed by stratified pooling 
procedures--weighted and semi-weighted pooling of measures. 
Results: individual analyses of the three studies gave evidence 
for equivalent efficacy of both treatments. The meta-analysis 
demonstrated very good evidence that after 3 weeks of treatment 
ERC is at least as effective as diclofenac in achieving both, 
improved knee function and decrease of pain. 
Conclusions: ERC may be considered as a valuable alternative 
to nonsteroidal anti-inflammatory drugs (NSAID) in the treatment 
of patients with osteoarthritis of the knee. This is the more so in 
situations where, due to the patient's history, the physician is 
reluctant o prescribe NSAID. 
